Tempus AI, Inc.
NASDAQ:TEMMedical - Healthcare Information Services
-$1.77 today
- Market cap
- $11.28B
- Beta
- 3.62
- P/E (TTM)
- -28.8
- EPS (TTM)
- -$1.69
Volume 5.35M
Average 6.17M
TEM Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Tempus AI, Inc.NASDAQ: TEM
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development dips below year-ago levels
Q3 FY2026 research & development of $45.71M fell 45.0% year over year, behind the +12.8% change in trailing-twelve-month research & development. Sequentially, it fell 52.7% from the prior quarter. Over 3 fiscal years it compounded at +25.3% a year.
Context
- Research & development amounted to 25.1% of revenue in FY2025, down 20.6 pp from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -45.0% toward the trailing-twelve-month pace of +12.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 319.03M USD
- Year-over-year change
- +0.7%
- 4-year CAGR
- +25.6%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 319.03M | +0.7% |
| FY2024 | 2024-12-31 | 316.84M | +70.8% |
| FY2023 | 2023-12-31 | 185.5M | +14.3% |
| FY2022 | 2022-12-31 | 162.25M | +26.4% |
| FY2021 | 2021-12-31 | 128.35M | — |
Research & Development vs competitors
How TEM compares with its peers on the latest reported figures
- TEM's LTM Sep 2026 research & development of $327.05M is the 4th highest of the 11 companies compared; the peer median is $82.81M.
- Its year-over-year change of +12.8% is the 4th highest of 10, against a peer median of +7.6%.
- Research & development amounts to 21.7% of revenue for TEM, versus a peer median of 13.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $958M | -3.4% | -10.4% | 21.3% | |
| LTM Jun 2026 | $787.38M | +56.9% | +25.4% | 29.1% | |
| LTM Sep 2026 | $386.67M | +7.6% | -0.9% | 30.2% | |
| LTM Sep 2026 | $327.05M | +12.8% | +25.3% | 21.7% | |
| LTM Jun 2026 | $194.67M | +5.5% | -0.4% | 9.3% | |
| LTM Mar 2026 | $106.4M | -7.7% | +7.7% | 12.8% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $59.21M | +38.6% | — | 14.9% |
| LTM Mar 2026 | $52.16M | +6.9% | -8.2% | 80.9% | |
| LTM Jun 2026 | $38.17M | +9.5% | +6.9% | 5.0% | |
| LTM Mar 2026 | $12.42M | +19.5% | -2.9% | 12.9% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TEM) | $82.81M | +7.6% | -0.6% | 13.9% | |
Competitors are the stored peer set for TEM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 257.85M | 320.67M | 531.82M | 693.4M | 1.27B |
| Cost of Revenue | 174.21M | 190.48M | 245.65M | 312.29M | 473.89M |
| Gross Profit | 83.64M | 130.19M | 286.18M | 381.11M | 797.9M |
| Gross Margin | 32.4% | 40.6% | 53.8% | 55.0% | 62.7% |
| Research & Development | 128.35M | 162.25M | 185.5M | 316.84M | 319.03M |
| Selling, General & Admin | 199M | 233.38M | 296.76M | 755.35M | 715.43M |
| Operating Expenses | 327.36M | 395.63M | 482.26M | 1.07B | 1.05B |
| Depreciation & Amortization | 23.88M | 30.41M | 33.33M | 37.25M | 102.32M |
| EBITDA | (219.52M) | (236.85M) | (133.33M) | (610.42M) | (118.51M) |
| EBITDA Margin | -85.1% | -73.9% | -25.1% | -88.0% | -9.3% |
| Operating Income | (243.71M) | (265.44M) | (196.08M) | (691.08M) | (252.87M) |
| Operating Margin | -94.5% | -82.8% | -36.9% | -99.7% | -19.9% |
| Interest Income | 623K | 3.03M | 7.6M | 11.08M | 12.63M |
| Interest Expense | 15.18M | 21.89M | 46.87M | 53.65M | 70.27M |
| Other Income / Expenses | (15.48M) | (24.3M) | (17.75M) | (14.46M) | (43.84M) |
| Income Before Tax | (259.19M) | (289.75M) | (213.83M) | (705.54M) | (296.71M) |
| Pre-Tax Margin | -100.5% | -90.4% | -40.2% | -101.8% | -23.3% |
| Income Tax Expense | 0 | 66K | 288K | 266K | (51.68M) |
| Net Income | (259.19M) | (289.81M) | (214.12M) | (705.81M) | (245.03M) |
| Net Margin | -100.5% | -90.4% | -40.3% | -101.8% | -19.3% |
| EPS (Basic) | (1.75) | (1.97) | (1.73) | (4.60) | (1.41) |
| EPS (Diluted) | (1.75) | (1.97) | (1.73) | (4.60) | (1.41) |
| Weighted Avg Shares | 169.88M | 169.88M | 154.17M | 162.12M | 174.26M |
| Weighted Avg Shares (Diluted) | 169.88M | 169.88M | 154.17M | 162.12M | 174.26M |
Tempus AI, Inc.
NASDAQ:TEM
Intrinsic Alpha fair value
Locked
Current Price
$63.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.